Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

키워드

참고문헌 (34)

1. Lee YH, "Nonlaboratory-based self-assessment screening score for non-alcoholic fatty liver disease : development, validation and comparison with other scores", PLoS One, 9, pp.e107584~ (2014)
2. Vernon G, "Systematic review : the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults", Aliment Pharmacol Ther, 34, pp.274~285 (2011)
3. Jeong-Ju Yoo, "Recent research trends and updates on nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 25(1), pp.1~11 (2019), 대한간학회
4. Angulo P, "The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD", Hepatology, 45, pp.846~854 (2007)
5. Angulo P, "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease", Gastroenterology, 149, pp.389~397 (2015)
6. Ekstedt M, "Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up", Hepatology, 61, pp.1547~1554 (2015)
7. Henson JB, "Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 51, pp.728~736 (2020)
8. Lloyd-Jones DM, "Lifetime risk for development of atrial fibrillation : the Framingham Heart Study", Circulation, 110, pp.1042~1046 (2004)
9. Kirchhof P, "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS", Eur J Cardiothorac Surg, 50, pp.e1~e88 (2016)
10. Wijarnpreecha K, "The association between non-alcoholic fatty liver disease and atrial fibrillation : a meta-analysis", Clin Res Hepatol Gastroenterol, 41, pp.525~532 (2017)
11. Francque SM, "Non-alcoholic fatty liver disease and cardiovascular risk : pathophysiological mechanisms and implications", J Hepatol, 65, pp.425~443 (2016)
12. Targher G, "Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes", PLoS One, 8, pp.e57183~ (2013)
13. Miller JD, "Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation", J Am Coll Cardiol, 66, pp.2899~2906 (2015)
14. Targher G, "Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2diabetes", Clin Sci(Lond), 125, pp.301~309 (2013)
15. McPherson S, "Age as a confounding factor for the accurate noninvasive diagnosis of advanced NAFLD fibrosis", Am J Gastroenterol, 112, pp.740~751 (2017)
16. Wong VW, "Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1 : definition, risk factors and assessment", J Gastroenterol Hepatol, 33, pp.70~85 (2018)
17. 오상우, "Obesity and Metabolic Syndrome in Korea", Diabetes and Metabolism Journal, 35(6), pp.561~566 (2011), 대한당뇨병학회
18. Peiris D, "Systematic medical assessment, referral and treatment for diabetes care in China using lay family health promoters : protocol for the SMARTDiabetes cluster randomised controlled trial", Implement Sci, 11, pp.116~ (2016)
19. Grundy SM, "Metabolic syndrome update", Trends Cardiovasc Med, 26, pp.364~373 (2016)
20. Mathiesen UL, "Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild", moderate abnormalities of liver transaminases, 2002, pp.34, 516~522
21. European Association for the Study of the Liver (EASL), "EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease", Obes Facts, 9, pp.65~90 (2016)
22. Sinner MF, "Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation", Am J Cardiol, 111, pp.219~224 (2013)
23. Alonso A, "Circulating levels of liver enzymes and incidence of atrial fibrillation : the Atherosclerosis Risk in Communities cohort", Heart, 100, pp.1511~1516 (2014)
24. Yoon HJ, "Causal relationship of non-alcoholic fatty liver disease with obesity and insulin resistance", J Korean Diabetes, 15, pp.76~81 (2014)
25. 문준성, "The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease", Diabetes and Metabolism Journal, 37(4), pp.278~285 (2013), 대한당뇨병학회[DOI]
26. Mantovani A, "Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease", Dig Dis Sci, 61, pp.1246~1267 (2016)
27. Kang MK, "Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 34, pp.1633~1640 (2019)
28. Ballestri S, "Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease", World J Gastroenterol, 20, pp.1724~1745 (2014)
29. Petta S, "Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 45, pp.510~518 (2017)
30. Liu YC, "Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability", PLoS One, 8, pp.e61803~ (2013)
31. Käräjämäki AJ, "Non-alcoholic fatty liver disease as a predictor of atrial fibrillation in middle-aged population(OPERA Study)", PLoS One, 10, pp.e0142937~ (2015)
32. Buzzetti E, "Noninvasive assessment of fibrosis in patients with nonalcoholic fatty liver disease", Int J Endocrinol, 2015, pp.343828~ (2015)
33. Lee SR, "Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population", Int J Cardiol, 236, pp.226~231 (2017)
34. Fontes JD, "Insulin resistance and atrial fibrillation(from the Framingham Heart Study)", Am J Cardiol, 109, pp.87~90 (2012)

관련 논문AI추천